Research Project
Grant-in-Aid for Challenging Exploratory Research
The tumor that is derived from the contaminated undifferentiated-cells is the major obstacle to the clinical application of human ES and/or iPS cell-based regenerative medicine. Here we developed a novel methodology that might conquer this obstacle to some degrees using m-CRA (conditionally replicating adenovirus with multiple tumor-specific factors), which we had initially developed for treating cancer. This methodology is not only a scientifically novel and original but also meaningful in terms of facilitating clinical development of these sorts of innovative therapy.
All 2014 2013 2012 2011 Other
All Journal Article (13 results) (of which Peer Reviewed: 13 results, Open Access: 1 results) Presentation (35 results) Remarks (1 results) Patent(Industrial Property Rights) (6 results) (of which Overseas: 3 results)
Int J Mol Med
Volume: 33(5) Issue: 5 Pages: 1064-1074
10.3892/ijmm.2014.1686
J Trans Med
Volume: 12 Issue: 1 Pages: 27-27
10.1186/1479-5876-12-27
Open journal of Cell biology
Volume: 2 Issue: 04 Pages: 179-185
10.4236/cellbio.2013.24020
PLoS ONE
Volume: 7(4) Issue: 4 Pages: e35354-e35354
10.1371/journal.pone.0035354
Nat. Commun
Volume: 27;3 Issue: 1 Pages: 758-758
10.1038/ncomms1755
Biochem. Biophys. Res. Commun
Volume: 413(1) Pages: 128-35
Cancer Gene Ther
Volume: 18(10) Pages: 724-33
Hepatol Res
Volume: 41(6) Pages: 594-596
Pediatr Surg Int
Volume: 27(8) Pages: 863-70
Biochem. Biophys. Res. Commun.
Volume: 16 Pages: 128-135
Cancer Gene Ther.
Volume: 18 Pages: 724-733
Hepatol Res.
Volume: 41 Pages: 594-596
Pediatr Surg Int.
Volume: 27 Pages: 863-870
http://www.kufm.kagoshima-u.ac.jp/~anatomy2/